1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Drugs for Malaria Consumption 2015-2025

2.1.2 Drugs for Malaria Consumption CAGR by Region

2.2 Drugs for Malaria Segment by Type

2.2.1 Aryl Aminoalcohol Compounds

2.2.2 Antifolate Compounds

2.2.3 Artemisinin Compounds

2.3 Drugs for Malaria Consumption by Type

2.3.1 Global Drugs for Malaria Consumption Market Share by Type (2015-2020)

2.3.2 Global Drugs for Malaria Revenue and Market Share by Type (2015-2020)

2.3.3 Global Drugs for Malaria Sale Price by Type (2015-2020)

2.4 Drugs for Malaria Segment by Application

2.4.1 Prevention

2.4.2 Treatment

2.4.3 Other

2.5 Drugs for Malaria Consumption by Application

2.5.1 Global Drugs for Malaria Consumption Market Share by Type (2015-2020)

2.5.2 Global Drugs for Malaria Value and Market Share by Type (2015-2020)

2.5.3 Global Drugs for Malaria Sale Price by Type (2015-2020)

3 Global Drugs for Malaria by Company

3.1 Global Drugs for Malaria Sales Market Share by Company

3.1.1 Global Drugs for Malaria Sales by Company (2018-2020)

3.1.2 Global Drugs for Malaria Sales Market Share by Company (2018-2020)

3.2 Global Drugs for Malaria Revenue Market Share by Company

3.2.1 Global Drugs for Malaria Revenue by Company (2018-2020)

3.2.2 Global Drugs for Malaria Revenue Market Share by Company (2018-2020)

3.3 Global Drugs for Malaria Sale Price by Company

3.4 Global Drugs for Malaria Manufacturing Base Distribution, Sales Area, Type by Company

3.4.1 Global Drugs for Malaria Manufacturing Base Distribution and Sales Area by Company

3.4.2 Players Drugs for Malaria Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Drugs for Malaria by Regions

4.1 Drugs for Malaria by Regions

4.2 Americas Drugs for Malaria Consumption Growth

4.3 APAC Drugs for Malaria Consumption Growth

4.4 Europe Drugs for Malaria Consumption Growth

4.5 Middle East & Africa Drugs for Malaria Consumption Growth

5 Americas

5.1 Americas Drugs for Malaria Consumption by Countries

5.1.1 Americas Drugs for Malaria Consumption by Countries (2015-2020)

5.1.2 Americas Drugs for Malaria Value by Countries (2015-2020)

5.2 Americas Drugs for Malaria Consumption by Type

5.3 Americas Drugs for Malaria Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

5.8 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Drugs for Malaria Consumption by Regions

6.1.1 APAC Drugs for Malaria Consumption by Regions (2015-2020)

6.1.2 APAC Drugs for Malaria Value by Regions (2015-2020)

6.2 APAC Drugs for Malaria Consumption by Type

6.3 APAC Drugs for Malaria Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Regions

7 Europe

7.1 Europe Drugs for Malaria by Countries

7.1.1 Europe Drugs for Malaria Consumption by Countries (2015-2020)

7.1.2 Europe Drugs for Malaria Value by Countries (2015-2020)

7.2 Europe Drugs for Malaria Consumption by Type

7.3 Europe Drugs for Malaria Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Drugs for Malaria by Countries

8.1.1 Middle East & Africa Drugs for Malaria Consumption by Countries (2015-2020)

8.1.2 Middle East & Africa Drugs for Malaria Value by Countries (2015-2020)

8.2 Middle East & Africa Drugs for Malaria Consumption by Type

8.3 Middle East & Africa Drugs for Malaria Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Drugs for Malaria Distributors

10.3 Drugs for Malaria Customer

11 Global Drugs for Malaria Market Forecast

11.1 Global Drugs for Malaria Consumption Forecast (2021-2025)

11.2 Global Drugs for Malaria Forecast by Regions

11.2.1 Global Drugs for Malaria Forecast by Regions (2021-2025)

11.2.2 Global Drugs for Malaria Value Forecast by Regions (2021-2025)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Drugs for Malaria Forecast by Type

11.8 Global Drugs for Malaria Forecast by Application

12 Key Players Analysis

12.1 Cipla

12.1.1 Company Information

12.1.2 Drugs for Malaria Product Offered

12.1.3 Cipla Drugs for Malaria Sales, Revenue, Price and Gross Margin (2018-2020)

12.1.4 Main Business Overview

12.1.5 Cipla Latest Developments

12.2 Guilin Pharmaceutical

12.2.1 Company Information

12.2.2 Drugs for Malaria Product Offered

12.2.3 Guilin Pharmaceutical Drugs for Malaria Sales, Revenue, Price and Gross Margin (2018-2020)

12.2.4 Main Business Overview

12.2.5 Guilin Pharmaceutical Latest Developments

12.3 GlaxoSmithKline

12.3.1 Company Information

12.3.2 Drugs for Malaria Product Offered

12.3.3 GlaxoSmithKline Drugs for Malaria Sales, Revenue, Price and Gross Margin (2018-2020)

12.3.4 Main Business Overview

12.3.5 GlaxoSmithKline Latest Developments

12.4 Mylan Labs

12.4.1 Company Information

12.4.2 Drugs for Malaria Product Offered

12.4.3 Mylan Labs Drugs for Malaria Sales, Revenue, Price and Gross Margin (2018-2020)

12.4.4 Main Business Overview

12.4.5 Mylan Labs Latest Developments

12.5 IPCA Laboratories

12.5.1 Company Information

12.5.2 Drugs for Malaria Product Offered

12.5.3 IPCA Laboratories Drugs for Malaria Sales, Revenue, Price and Gross Margin (2018-2020)

12.5.4 Main Business Overview

12.5.5 IPCA Laboratories Latest Developments

12.6 Sanofi Aventis

12.6.1 Company Information

12.6.2 Drugs for Malaria Product Offered

12.6.3 Sanofi Aventis Drugs for Malaria Sales, Revenue, Price and Gross Margin (2018-2020)

12.6.4 Main Business Overview

12.6.5 Sanofi Aventis Latest Developments

12.7 Roche

12.7.1 Company Information

12.7.2 Drugs for Malaria Product Offered

12.7.3 Roche Drugs for Malaria Sales, Revenue, Price and Gross Margin (2018-2020)

12.7.4 Main Business Overview

12.7.5 Roche Latest Developments

12.8 Ajanta Pharma

12.8.1 Company Information

12.8.2 Drugs for Malaria Product Offered

12.8.3 Ajanta Pharma Drugs for Malaria Sales, Revenue, Price and Gross Margin (2018-2020)

12.8.4 Main Business Overview

12.8.5 Ajanta Pharma Latest Developments

12.9 Novartis

12.9.1 Company Information

12.9.2 Drugs for Malaria Product Offered

12.9.3 Novartis Drugs for Malaria Sales, Revenue, Price and Gross Margin (2018-2020)

12.9.4 Main Business Overview

12.9.5 Novartis Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology

Table 2. Data Source

Table 3. Drugs for Malaria Consumption CAGR by Region 2015-2025 ($ Millions)

Table 4. Major Players of Aryl Aminoalcohol Compounds

Table 5. Major Players of Antifolate Compounds

Table 6. Major Players of Artemisinin Compounds

Table 7. Global Consumption Sales by Type (2015-2020)

Table 8. Global Drugs for Malaria Consumption Market Share by Type (2015-2020)

Table 9. Global Drugs for Malaria Revenue by Type (2015-2020) ($ million)

Table 10. Global Drugs for Malaria Value Market Share by Type (2015-2020) ($ Millions)

Table 11. Global Drugs for Malaria Sale Price by Type (2015-2020)

Table 12. Global Consumption Sales by Application (2015-2020)

Table 13. Global Drugs for Malaria Consumption Market Share by Application (2015-2020)

Table 14. Global Drugs for Malaria Value by Application (2015-2020)

Table 15. Global Drugs for Malaria Value Market Share by Application (2015-2020)

Table 16. Global Drugs for Malaria Sale Price by Application (2015-2020)

Table 17. Global Drugs for Malaria Sales by Company (2017-2019) (K Units)

Table 18. Global Drugs for Malaria Sales Market Share by Company (2017-2019)

Table 19. Global Drugs for Malaria Revenue by Company (2017-2019) ($ Millions)

Table 20. Global Drugs for Malaria Revenue Market Share by Company (2017-2019)

Table 21. Global Drugs for Malaria Sale Price by Company (2017-2019)

Table 22. Global Drugs for Malaria Manufacturing Base Distribution and Sales Area by Manufacturers

Table 23. Players Drugs for Malaria Products Offered

Table 24. Drugs for Malaria Concentration Ratio (CR3, CR5 and CR10) (2017-2019)

Table 25. Global Drugs for Malaria Consumption by Regions 2015-2020 (K Units)

Table 26. Global Drugs for Malaria Consumption Market Share by Regions 2015-2020

Table 27. Global Drugs for Malaria Value by Regions 2015-2020 ($ Millions)

Table 28. Global Drugs for Malaria Value Market Share by Regions 2015-2020

Table 29. Americas Drugs for Malaria Consumption by Countries (2015-2020) (K Units)

Table 30. Americas Drugs for Malaria Consumption Market Share by Countries (2015-2020)

Table 31. Americas Drugs for Malaria Value by Countries (2015-2020) ($ Millions)

Table 32. Americas Drugs for Malaria Value Market Share by Countries (2015-2020)

Table 33. Americas Drugs for Malaria Consumption by Type (2015-2020) (K Units)

Table 34. Americas Drugs for Malaria Consumption Market Share by Type (2015-2020)

Table 35. Americas Drugs for Malaria Consumption by Application (2015-2020) (K Units)

Table 36. Americas Drugs for Malaria Consumption Market Share by Application (2015-2020)

Table 37. APAC Drugs for Malaria Consumption by Countries (2015-2020) (K Units)

Table 38. APAC Drugs for Malaria Consumption Market Share by Countries (2015-2020)

Table 39. APAC Drugs for Malaria Value by Regions (2015-2020) ($ Millions)

Table 40. APAC Drugs for Malaria Value Market Share by Regions (2015-2020)

Table 41. APAC Drugs for Malaria Consumption by Type (2015-2020) (K Units)

Table 42. APAC Drugs for Malaria Consumption Market Share by Type (2015-2020)

Table 43. APAC Drugs for Malaria Consumption by Application (2015-2020) (K Units)

Table 44. APAC Drugs for Malaria Consumption Market Share by Application (2015-2020)

Table 45. Europe Drugs for Malaria Consumption by Countries (2015-2020) (K Units)

Table 46. Europe Drugs for Malaria Consumption Market Share by Countries (2015-2020)

Table 47. Europe Drugs for Malaria Value by Countries (2015-2020) ($ Millions)

Table 48. Europe Drugs for Malaria Value Market Share by Countries (2015-2020)

Table 49. Europe Drugs for Malaria Consumption by Type (2015-2020) (K Units)

Table 50. Europe Drugs for Malaria Consumption Market Share by Type (2015-2020)

Table 51. Europe Drugs for Malaria Consumption by Application (2015-2020) (K Units)

Table 52. Europe Drugs for Malaria Consumption Market Share by Application (2015-2020)

Table 53. Middle East & Africa Drugs for Malaria Consumption by Countries (2015-2020) (K Units)

Table 54. Middle East & Africa Drugs for Malaria Consumption Market Share by Countries (2015-2020)

Table 55. Middle East & Africa Drugs for Malaria Value by Countries (2015-2020) ($ Millions)

Table 56. Middle East & Africa Drugs for Malaria Value Market Share by Countries (2015-2020)

Table 57. Middle East & Africa Drugs for Malaria Consumption by Type (2015-2020) (K Units)

Table 58. Middle East & Africa Drugs for Malaria Consumption Market Share by Type (2015-2020)

Table 59. Middle East & Africa Drugs for Malaria Consumption by Application (2015-2020) (K Units)

Table 60. Middle East & Africa Drugs for Malaria Consumption Market Share by Application (2015-2020)

Table 61. Drugs for Malaria Distributors List

Table 62. Drugs for Malaria Customer List

Table 63. Global Drugs for Malaria Consumption Forecast by Countries (2021-2025) (K Units)

Table 64. Global Drugs for Malaria Consumption Market Forecast by Regions

Table 65. Global Drugs for Malaria Value Forecast by Countries (2021-2025) ($ Millions)

Table 66. Global Drugs for Malaria Value Market Share Forecast by Regions

Table 67. Global Drugs for Malaria Consumption Forecast by Type (2021-2025) (K Units)

Table 68. Global Drugs for Malaria Consumption Market Share Forecast by Type (2021-2025)

Table 69. Global Drugs for Malaria Value Forecast by Type (2021-2025) ($ Millions)

Table 70. Global Drugs for Malaria Value Market Share Forecast by Type (2021-2025)

Table 71. Global Drugs for Malaria Consumption Forecast by Application (2021-2025) (K Units)

Table 72. Global Drugs for Malaria Consumption Market Share Forecast by Application (2021-2025)

Table 73. Global Drugs for Malaria Value Forecast by Application (2021-2025) ($ Millions)

Table 74. Global Drugs for Malaria Value Market Share Forecast by Application (2021-2025)

Table 75. Cipla Product Offered

Table 76. Cipla Drugs for Malaria Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 77. Cipla Main Business

Table 78. Cipla Latest Developments

Table 79. Cipla Basic Information, Company Total Revenue (in $ million), Drugs for Malaria Manufacturing Base, Sales Area and Its Competitors

Table 80. Guilin Pharmaceutical Product Offered

Table 81. Guilin Pharmaceutical Drugs for Malaria Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 82. Guilin Pharmaceutical Main Business

Table 83. Guilin Pharmaceutical Latest Developments

Table 84. Guilin Pharmaceutical Basic Information, Company Total Revenue (in $ million), Drugs for Malaria Manufacturing Base, Sales Area and Its Competitors

Table 85. GlaxoSmithKline Product Offered

Table 86. GlaxoSmithKline Drugs for Malaria Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 87. GlaxoSmithKline Main Business

Table 88. GlaxoSmithKline Latest Developments

Table 89. GlaxoSmithKline Basic Information, Company Total Revenue (in $ million), Drugs for Malaria Manufacturing Base, Sales Area and Its Competitors

Table 90. Mylan Labs Product Offered

Table 91. Mylan Labs Drugs for Malaria Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 92. Mylan Labs Main Business

Table 93. Mylan Labs Latest Developments

Table 94. Mylan Labs Basic Information, Company Total Revenue (in $ million), Drugs for Malaria Manufacturing Base, Sales Area and Its Competitors

Table 95. IPCA Laboratories Product Offered

Table 96. IPCA Laboratories Drugs for Malaria Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 97. IPCA Laboratories Main Business

Table 98. IPCA Laboratories Latest Developments

Table 99. IPCA Laboratories Basic Information, Company Total Revenue (in $ million), Drugs for Malaria Manufacturing Base, Sales Area and Its Competitors

Table 100. Sanofi Aventis Product Offered

Table 101. Sanofi Aventis Drugs for Malaria Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 102. Sanofi Aventis Main Business

Table 103. Sanofi Aventis Latest Developments

Table 104. Sanofi Aventis Basic Information, Company Total Revenue (in $ million), Drugs for Malaria Manufacturing Base, Sales Area and Its Competitors

Table 105. Roche Product Offered

Table 106. Roche Basic Information, Company Total Revenue (in $ million), Drugs for Malaria Manufacturing Base, Sales Area and Its Competitors

Table 107. Roche Main Business

Table 108. Roche Latest Developments

Table 109. Roche Drugs for Malaria Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 110. Ajanta Pharma Product Offered

Table 111. Ajanta Pharma Drugs for Malaria Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 112. Ajanta Pharma Main Business

Table 113. Ajanta Pharma Latest Developments

Table 114. Ajanta Pharma Basic Information, Company Total Revenue (in $ million), Drugs for Malaria Manufacturing Base, Sales Area and Its Competitors

Table 115. Novartis Product Offered

Table 116. Novartis Drugs for Malaria Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 117. Novartis Main Business

Table 118. Novartis Latest Developments

Table 119. Novartis Basic Information, Company Total Revenue (in $ million), Drugs for Malaria Manufacturing Base, Sales Area and Its Competitors

List of Figures

Figure 1. Picture of Drugs for Malaria

Figure 2. Drugs for Malaria Report Years Considered

Figure 3. Market Research Methodology

Figure 4. Global Drugs for Malaria Consumption Growth Rate 2015-2025 (K Units)

Figure 5. Global Drugs for Malaria Value Growth Rate 2015-2025 ($ Millions)

Figure 6. Product Picture of Aryl Aminoalcohol Compounds

Figure 7. Product Picture of Antifolate Compounds

Figure 8. Product Picture of Artemisinin Compounds

Figure 9. Global Drugs for Malaria Consumption Market Share by Type (2015-2020)

Figure 10. Global Drugs for Malaria Value Market Share by Type (2015-2020)

Figure 11. Drugs for Malaria Consumed in Prevention

Figure 12. Global Drugs for Malaria Market: Prevention (2015-2020) (K Units)

Figure 13. Global Drugs for Malaria Market: Prevention (2015-2020) ($ Millions)

Figure 14. Drugs for Malaria Consumed in Treatment

Figure 15. Global Drugs for Malaria Market: Treatment (2015-2020) (K Units)

Figure 16. Global Drugs for Malaria Market: Treatment (2015-2020) ($ Millions)

Figure 17. Drugs for Malaria Consumed in Other

Figure 18. Global Drugs for Malaria Market: Other (2015-2020) (K Units)

Figure 19. Global Drugs for Malaria Market: Other (2015-2020) ($ Millions)

Figure 20. Global Drugs for Malaria Consumption Market Share by Application (2015-2020)

Figure 21. Global Drugs for Malaria Value Market Share by Application (2015-2020)

Figure 22. Global Drugs for Malaria Sales Market Share by Company in 2017

Figure 23. Global Drugs for Malaria Sales Market Share by Company in 2019

Figure 24. Global Drugs for Malaria Revenue Market Share by Company in 2017

Figure 25. Global Drugs for Malaria Revenue Market Share by Company in 2019

Figure 26. Global Drugs for Malaria Sale Price by Company in 2019

Figure 27. Global Drugs for Malaria Consumption Market Share by Regions 2015-2020

Figure 28. Global Drugs for Malaria Value Market Share by Regions 2015-2020

Figure 29. Americas Drugs for Malaria Consumption 2015-2020 (K Units)

Figure 30. Americas Drugs for Malaria Value 2015-2020 ($ Millions)

Figure 31. APAC Drugs for Malaria Consumption 2015-2020 (K Units)

Figure 32. APAC Drugs for Malaria Value 2015-2020 ($ Millions)

Figure 33. Europe Drugs for Malaria Consumption 2015-2020 (K Units)

Figure 34. Europe Drugs for Malaria Value 2015-2020 ($ Millions)

Figure 35. Middle East & Africa Drugs for Malaria Consumption 2015-2020 (K Units)

Figure 36. Middle East & Africa Drugs for Malaria Value 2015-2020 ($ Millions)

Figure 37. Americas Drugs for Malaria Consumption Market Share by Countries in 2019

Figure 38. Americas Drugs for Malaria Value Market Share by Countries in 2019

Figure 39. Americas Drugs for Malaria Consumption Market Share by Type in 2019

Figure 40. Americas Drugs for Malaria Consumption Market Share by Application in 2019

Figure 41. United States Drugs for Malaria Consumption Growth 2015-2020 (K Units)

Figure 42. United States Drugs for Malaria Value Growth 2015-2020 ($ Millions)

Figure 43. Canada Drugs for Malaria Consumption Growth 2015-2020 (K Units)

Figure 44. Canada Drugs for Malaria Value Growth 2015-2020 ($ Millions)

Figure 45. Mexico Drugs for Malaria Consumption Growth 2015-2020 (K Units)

Figure 46. Mexico Drugs for Malaria Value Growth 2015-2020 ($ Millions)

Figure 47. APAC Drugs for Malaria Consumption Market Share by Countries in 2019

Figure 48. APAC Drugs for Malaria Value Market Share by Regions in 2019

Figure 49. APAC Drugs for Malaria Consumption Market Share by Type in 2019

Figure 50. APAC Drugs for Malaria Consumption Market Share by Application in 2019

Figure 51. China Drugs for Malaria Consumption Growth 2015-2020 (K Units)

Figure 52. China Drugs for Malaria Value Growth 2015-2020 ($ Millions)

Figure 53. Japan Drugs for Malaria Consumption Growth 2015-2020 (K Units)

Figure 54. Japan Drugs for Malaria Value Growth 2015-2020 ($ Millions)

Figure 55. Korea Drugs for Malaria Consumption Growth 2015-2020 (K Units)

Figure 56. Korea Drugs for Malaria Value Growth 2015-2020 ($ Millions)

Figure 57. Southeast Asia Drugs for Malaria Consumption Growth 2015-2020 (K Units)

Figure 58. Southeast Asia Drugs for Malaria Value Growth 2015-2020 ($ Millions)

Figure 59. India Drugs for Malaria Consumption Growth 2015-2020 (K Units)

Figure 60. India Drugs for Malaria Value Growth 2015-2020 ($ Millions)

Figure 61. Australia Drugs for Malaria Consumption Growth 2015-2020 (K Units)

Figure 62. Australia Drugs for Malaria Value Growth 2015-2020 ($ Millions)

Figure 63. Europe Drugs for Malaria Consumption Market Share by Countries in 2019

Figure 64. Europe Drugs for Malaria Value Market Share by Countries in 2019

Figure 65. Europe Drugs for Malaria Consumption Market Share by Type in 2019

Figure 66. Europe Drugs for Malaria Consumption Market Share by Application in 2019

Figure 67. Germany Drugs for Malaria Consumption Growth 2015-2020 (K Units)

Figure 68. Germany Drugs for Malaria Value Growth 2015-2020 ($ Millions)

Figure 69. France Drugs for Malaria Consumption Growth 2015-2020 (K Units)

Figure 70. France Drugs for Malaria Value Growth 2015-2020 ($ Millions)

Figure 71. UK Drugs for Malaria Consumption Growth 2015-2020 (K Units)

Figure 72. UK Drugs for Malaria Value Growth 2015-2020 ($ Millions)

Figure 73. Italy Drugs for Malaria Consumption Growth 2015-2020 (K Units)

Figure 74. Italy Drugs for Malaria Value Growth 2015-2020 ($ Millions)

Figure 75. Russia Drugs for Malaria Consumption Growth 2015-2020 (K Units)

Figure 76. Russia Drugs for Malaria Value Growth 2015-2020 ($ Millions)

Figure 77. Middle East & Africa Drugs for Malaria Consumption Market Share by Countries in 2019

Figure 78. Middle East & Africa Drugs for Malaria Value Market Share by Countries in 2019

Figure 79. Middle East & Africa Drugs for Malaria Consumption Market Share by Type in 2019

Figure 80. Middle East & Africa Drugs for Malaria Consumption Market Share by Application in 2019

Figure 81. Egypt Drugs for Malaria Consumption Growth 2015-2020 (K Units)

Figure 82. Egypt Drugs for Malaria Value Growth 2015-2020 ($ Millions)

Figure 83. South Africa Drugs for Malaria Consumption Growth 2015-2020 (K Units)

Figure 84. South Africa Drugs for Malaria Value Growth 2015-2020 ($ Millions)

Figure 85. Israel Drugs for Malaria Consumption Growth 2015-2020 (K Units)

Figure 86. Israel Drugs for Malaria Value Growth 2015-2020 ($ Millions)

Figure 87. Turkey Drugs for Malaria Consumption Growth 2015-2020 (K Units)

Figure 88. Turkey Drugs for Malaria Value Growth 2015-2020 ($ Millions)

Figure 89. GCC Countries Drugs for Malaria Consumption Growth 2015-2020 (K Units)

Figure 90. GCC Countries Drugs for Malaria Value Growth 2015-2020 ($ Millions)

Figure 91. Global Drugs for Malaria Consumption Growth Rate Forecast (2021-2025) (K Units)

Figure 92. Global Drugs for Malaria Value Growth Rate Forecast (2021-2025) ($ Millions)

Figure 93. Americas Drugs for Malaria Consumption 2021-2025 (K Units)

Figure 94. Americas Drugs for Malaria Value 2021-2025 ($ Millions)

Figure 95. APAC Drugs for Malaria Consumption 2021-2025 (K Units)

Figure 96. APAC Drugs for Malaria Value 2021-2025 ($ Millions)

Figure 97. Europe Drugs for Malaria Consumption 2021-2025 (K Units)

Figure 98. Europe Drugs for Malaria Value 2021-2025 ($ Millions)

Figure 99. Middle East & Africa Drugs for Malaria Consumption 2021-2025 (K Units)

Figure 100. Middle East & Africa Drugs for Malaria Value 2021-2025 ($ Millions)

Figure 101. United States Drugs for Malaria Consumption 2021-2025 (K Units)

Figure 102. United States Drugs for Malaria Value 2021-2025 ($ Millions)

Figure 103. Canada Drugs for Malaria Consumption 2021-2025 (K Units)

Figure 104. Canada Drugs for Malaria Value 2021-2025 ($ Millions)

Figure 105. Mexico Drugs for Malaria Consumption 2021-2025 (K Units)

Figure 106. Mexico Drugs for Malaria Value 2021-2025 ($ Millions)

Figure 107. Brazil Drugs for Malaria Consumption 2021-2025 (K Units)

Figure 108. Brazil Drugs for Malaria Value 2021-2025 ($ Millions)

Figure 109. China Drugs for Malaria Consumption 2021-2025 (K Units)

Figure 110. China Drugs for Malaria Value 2021-2025 ($ Millions)

Figure 111. Japan Drugs for Malaria Consumption 2021-2025 (K Units)

Figure 112. Japan Drugs for Malaria Value 2021-2025 ($ Millions)

Figure 113. Korea Drugs for Malaria Consumption 2021-2025 (K Units)

Figure 114. Korea Drugs for Malaria Value 2021-2025 ($ Millions)

Figure 115. Southeast Asia Drugs for Malaria Consumption 2021-2025 (K Units)

Figure 116. Southeast Asia Drugs for Malaria Value 2021-2025 ($ Millions)

Figure 117. India Drugs for Malaria Consumption 2021-2025 (K Units)

Figure 118. India Drugs for Malaria Value 2021-2025 ($ Millions)

Figure 119. Australia Drugs for Malaria Consumption 2021-2025 (K Units)

Figure 120. Australia Drugs for Malaria Value 2021-2025 ($ Millions)

Figure 121. Germany Drugs for Malaria Consumption 2021-2025 (K Units)

Figure 122. Germany Drugs for Malaria Value 2021-2025 ($ Millions)

Figure 123. France Drugs for Malaria Consumption 2021-2025 (K Units)

Figure 124. France Drugs for Malaria Value 2021-2025 ($ Millions)

Figure 125. UK Drugs for Malaria Consumption 2021-2025 (K Units)

Figure 126. UK Drugs for Malaria Value 2021-2025 ($ Millions)

Figure 127. Italy Drugs for Malaria Consumption 2021-2025 (K Units)

Figure 128. Italy Drugs for Malaria Value 2021-2025 ($ Millions)

Figure 129. Russia Drugs for Malaria Consumption 2021-2025 (K Units)

Figure 130. Russia Drugs for Malaria Value 2021-2025 ($ Millions)

Figure 131. Spain Drugs for Malaria Consumption 2021-2025 (K Units)

Figure 132. Spain Drugs for Malaria Value 2021-2025 ($ Millions)

Figure 133. Egypt Drugs for Malaria Consumption 2021-2025 (K Units)

Figure 134. Egypt Drugs for Malaria Value 2021-2025 ($ Millions)

Figure 135. South Africa Drugs for Malaria Consumption 2021-2025 (K Units)

Figure 136. South Africa Drugs for Malaria Value 2021-2025 ($ Millions)

Figure 137. Israel Drugs for Malaria Consumption 2021-2025 (K Units)

Figure 138. Israel Drugs for Malaria Value 2021-2025 ($ Millions)

Figure 139. Turkey Drugs for Malaria Consumption 2021-2025 (K Units)

Figure 140. Turkey Drugs for Malaria Value 2021-2025 ($ Millions)

Figure 141. GCC Countries Drugs for Malaria Consumption 2021-2025 (K Units)

Figure 142. GCC Countries Drugs for Malaria Value 2021-2025 ($ Millions)

Figure 143. Cipla Drugs for Malaria Market Share (2018-2020)

Figure 144. Guilin Pharmaceutical Drugs for Malaria Market Share (2018-2020)

Figure 145. GlaxoSmithKline Drugs for Malaria Market Share (2018-2020)

Figure 146. Mylan Labs Drugs for Malaria Market Share (2018-2020)

Figure 147. IPCA Laboratories Drugs for Malaria Market Share (2018-2020)

Figure 148. Sanofi Aventis Drugs for Malaria Market Share (2018-2020)

Figure 149. Roche Drugs for Malaria Market Share (2018-2020)

Figure 150. Ajanta Pharma Drugs for Malaria Market Share (2018-2020)

Figure 151. Novartis Drugs for Malaria Market Share (2018-2020)